Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases
European Journal of Cancer2013Vol. 50(2), pp. 332–340
Citations Over TimeTop 1% of 2013 papers
D. Élias, Diane Goèré, Frédéric Dumont, Charles Honoré, Peggy Dartigues, Annabelle Stoclin, David Malka, Valérie Boige, Michel Ducreux
Related Papers
- → Outcomes following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancies: 10 Year experience(2024)5 cited
- → Surgical morbidity and mortality in patients undergoing extended cytoreductive surgery with hyperthermic intraperitoneal chemotherapy(2012)
- → 02 / Postoperative outcomes of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC)(2018)
- → Assessing morbidity, mortality, and survival in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy(2023)